Summary of CDC consultations related to nontraditional therapies and settings, 2016–2023
This summary highlights the potential infectious risks to consumers posed by nontraditional therapies, which may have unproven benefits and poorly defined risks. With continued expansion of nontraditional therapies and settings, consumers will benefit from education, training, and oversight of those who provide therapies in these settings.
Authors
- Kevin B. Spicer (ORCID: https://orcid.org/0000-0001-7154-8020)
- Joseph F. Perz (ORCID: https://orcid.org/0000-0002-1706-8787)
- Elizabeth Beshearse (ORCID: https://orcid.org/0000-0001-7799-6078)
- Kiran M. Perkins (ORCID: https://orcid.org/0000-0003-0951-4318)
Institutions
- National Center for Emerging and Zoonotic Infectious Diseases (US)
Publication Details
- Journal
- Infection Control and Hospital Epidemiology
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1017/ice.2025.10323
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00